Marshall Wace, LLP United Therapeutics Corp Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

A detailed history of Marshall Wace, LLP transactions in United Therapeutics Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 12,708 shares of UTHR stock, worth $4.59 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,708
Previous 20,105 36.79%
Holding current value
$4.59 Million
Previous $6.4 Million 28.9%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$311.04 - $363.55 $2.3 Million - $2.69 Million
-7,397 Reduced 36.79%
12,708 $4.55 Million
Q2 2024

Aug 14, 2024
SELL
$228.26 - $319.04 $24.1 Million - $33.7 Million
-105,538 Reduced 84.0%
20,105 $6.4 Million
Q1 2024

May 15, 2024
BUY
$210.76 - $249.51 $24.4 Million - $28.9 Million
115,788 Added 1174.92%
125,643 $28.9 Million
Q4 2023

Feb 14, 2024
BUY
$214.88 - $256.94 $1.59 Million - $1.9 Million
7,407 Added 302.57%
9,855 $2.17 Million
Q3 2023

Nov 14, 2023
BUY
$211.82 - $248.24 $518,535 - $607,691
2,448 New
2,448 $552,000
Q4 2022

Feb 14, 2023
BUY
$205.95 - $280.43 $950,047 - $1.29 Million
4,613 New
4,613 $1.28 Million
Q2 2022

Aug 15, 2022
SELL
$174.81 - $241.14 $4.75 Million - $6.55 Million
-27,151 Reduced 91.73%
2,449 $577,000
Q1 2022

May 16, 2022
BUY
$166.16 - $213.96 $4.92 Million - $6.33 Million
29,600 New
29,600 $5.31 Million
Q4 2021

Feb 14, 2022
SELL
$184.32 - $216.08 $3.95 Million - $4.63 Million
-21,422 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$179.86 - $214.88 $3.85 Million - $4.6 Million
21,422 New
21,422 $3.95 Million
Q2 2021

Aug 13, 2021
SELL
$170.47 - $211.93 $337,189 - $419,197
-1,978 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$153.94 - $174.85 $585,587 - $665,129
-3,804 Reduced 65.79%
1,978 $331,000
Q4 2020

Feb 16, 2021
SELL
$101.87 - $151.79 $630,982 - $940,187
-6,194 Reduced 51.72%
5,782 $878,000
Q3 2020

Nov 16, 2020
SELL
$99.9 - $121.13 $1.36 Million - $1.65 Million
-13,661 Reduced 53.29%
11,976 $1.21 Million
Q2 2020

Aug 13, 2020
BUY
$92.74 - $125.82 $2.38 Million - $3.23 Million
25,637 New
25,637 $3.1 Million
Q1 2020

May 15, 2020
SELL
$79.39 - $115.35 $441,884 - $642,038
-5,566 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$78.31 - $95.34 $435,873 - $530,662
5,566 New
5,566 $490,000
Q1 2019

May 14, 2019
SELL
$107.15 - $126.84 $1.91 Million - $2.26 Million
-17,819 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$101.4 - $128.73 $1.81 Million - $2.29 Million
17,819 New
17,819 $1.94 Million
Q3 2018

Nov 14, 2018
SELL
$113.81 - $129.46 $378,645 - $430,713
-3,327 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$101.14 - $118.31 $336,492 - $393,617
3,327 New
3,327 $376,000

Others Institutions Holding UTHR

# of Institutions
671
Shares Held
42.3M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email